Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO
13 January 2022 - 1:00AM
Business Wire
Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a
biotech innovation company with a mission to improve the health of
the immune system, today announced it will host an online business
update townhall meeting with Amro Albanna, Co-Founder & CEO on
Tuesday, January 18th from 2:00 to 3:00 pm ET.
The upcoming meeting will include, but is not limited to,
commentary on the following topics:
- A business update and upcoming milestones
- A summary and discussion of revenue strategy
- An overview of the acquisition strategy
The online meeting will be followed by Q&A. All investors
are invited to attend, whether professional or individual.
All questions can be submitted in advance via email:
aditxt@edisongroup.com.
To join the webinar, CLICK HERE Or paste the link directly into
your browser:
https://edisongroup.zoom.us/webinar/register/WN_fuO3kop7RqaETiLhfzzqyA
About Aditxt™
Aditxt develops technologies focused on improving immune system
health through immune monitoring and reprogramming. Aditxt’s immune
monitoring technology is designed to provide a personalized,
comprehensive system immune system profile. Aditxt’s immune
reprogramming technology, currently preclinical, is designed to
retrain the immune system to induce tolerance to address rejection
of transplanted organs, autoimmune diseases, and allergies.
AditxtScore™ for COVID-19 is Aditxt’s proprietary immune profile
technology to equip people with information about their level of
protection. For more information, please visit: www.aditxt.com and
www.AditxtScore.com.
Forward-Looking Statements
Certain statements in this press release constitute
“forward-looking statements” within the meaning of federal
securities laws. All statements other than historical fact
contained in this press release, including, without limitation,
statements regarding the Company’s intentions, beliefs,
projections, outlook, analyses, or current expectations concerning,
among other things, the Company’s ongoing and planned product and
business development, revenue strategy and acquisition strategy;
the Company’s intellectual property position; the Company’s ability
to develop commercial functions; expectations regarding product
launch and revenue; the Company’s results of operations, cash
needs, spending, financial condition, liquidity, prospects, growth
and strategies; the industry in which the Company operates; and the
trends that may affect the industry or the Company, are
forward-looking statements. Forward-looking statements are not
guarantees of future performance, and actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors, as well as those risks
more fully discussed in the section titled “Risk Factors” in the
Company’s most recent Annual Report on Form 10-K, as well as
discussions of potential risks, uncertainties, and other essential
factors in the Company’s other filings with the Securities and
Exchange Commission. All such statements speak only as of the date
made. The Company undertakes no obligation to update or revise
publicly any forward-looking statements, whether as a result of new
information, future events, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220112005412/en/
Media and Investor Relations Contact: Edison Investment Research
IR@aditxt.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Apr 2023 to Apr 2024